Earl, HM and Hiller, H and Vallier, A-L and Bowden, SJ and Jordan, SD and Blows, F and Munro, A and Bathers, S and Grieve, R and Spooner, DA and Agrawal, R and Fernando, I and Brunt, AM and O'Reilly, SM and Crawford, SM and Rea, DW and Simmonds, P and Mansi, JL and Stanley, A and McAdam, K and Foster, L and Leonard, RCF and Twelves, CJ and Cameron, D and Bartlett, JMS and Pharoah, P and Provenzano, E and Caldas, C and Poole, CJ (2012) Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials. British Journal of Cancer, 107 (8). pp. 1257-1267. ISSN 1532-1827

[img]
Preview
Text
bjc2012370a.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (863kB) | Preview
Item Type: Article
Additional Information: This is the final published version of the article (version of record). It first appeared online via Nature Publishing Group at http://dx.doi.org/10.1038/bjc.2012.370 - please refer to any applicable terms of use of the publisher.
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine and Health Sciences > Institute for Science and Technology in Medicine
Depositing User: Symplectic
Date Deposited: 06 Apr 2017 15:18
Last Modified: 06 Apr 2017 15:32
URI: http://eprints.keele.ac.uk/id/eprint/3177

Actions (login required)

View Item View Item